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916 The Journal of Thoracic and CardioObjectives: We sought to characterize the temporal return of mitral regurgitation
after annuloplasty for functional ischemic mitral regurgitation; to identify its pre-
dictors, particularly with respect to annuloplasty type; and to determine whether
annuloplasty type influences survival.
Methods: From April 1985 through November 2002, 585 patients underwent annu-
loplasty alone for repair of functional ischemic mitral regurgitation, generally with
concomitant coronary revascularization (95%). A flexible band (Cosgrove) was
used in 68%, a rigid ring (Carpentier) in 21%, and bovine pericardial annuloplasty
(Peri-Guard) in 11%. Six hundred seventy-eight postoperative echocardiograms
were available in 422 patients to assess the time course of postoperative mitral
regurgitation and its correlates. Most echocardiograms were performed early after
the operation (median, 8 days); 17% were performed at 1 year or beyond.
Results: During the first 6 months after repair, the proportion of patients with 0 or
1 mitral regurgitation decreased from 71% to 41%, whereas the proportion with
3 or 4 regurgitation increased from 13% to 28% (P  .0001); the regurgitation
grade was stable thereafter. The temporal pattern of development of 3 or 4
regurgitation was similar for Cosgrove bands and Carpentier rings (25%) but
substantially worse for Peri-Guard annuloplasties (66%). Small annuloplasty size
did not influence postoperative regurgitation grade (P  .2), although Cosgrove
bands were used in most patients receiving 26- and 28-mm annuloplasties. Freedom
from reoperation was 97% at 5 years. Annuloplasty type was not associated with
survival.
Conclusions: Although initial mitral valve replacement would eliminate the risk of
postoperative mitral regurgitation, this strategy has been associated with reduced
survival. Therefore the development of additional techniques is necessary to achieve
more secure repair of functional ischemic mitral regurgitation.
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CDOptimal surgical treatment of functionalischemic mitral regurgitation (IMR) iscontroversial. Valve repair generally con-sists of annuloplasty alone,1-4 but there isdebate concerning the effect of annulo-plasty type and size on the durability of
repair, and there are few data comparing different annulo-
plasty strategies.1-3,5-8
The objectives of this study were to (1) characterize the
temporal return of mitral regurgitation (MR) after annulo-
plasty alone for functional IMR; (2) to identify risk factors
for the return of MR, particularly with respect to annulo-
plasty type; and (3) to determine whether annuloplasty type
influences survival.
Patients and Methods
Study Group
From April 1985 through November 2002, 585 patients underwent
annuloplasty alone for repair of functional IMR (see the “Defini-
tions” section) at The Cleveland Clinic Foundation. All had at least
2 (moderate) MR on echocardiography, left ventriculography, or
both.
Concomitant procedures included coronary artery bypass graft-
ing (585 [95%] patients) and tricuspid valve repair (62 [11%]
patients). Patients who underwent a concomitant aortic valve pro-
cedure or left ventricular restoration were excluded.
Annuloplasty types included the Carpentier-Edwards Classic
annuloplasty ring (n  122 [21%]; Carpentier ring; Edwards
Lifesciences, Irvine, Calif), the Cosgrove-Edwards annuloplasty
system (n  396 [68%]; Cosgrove band; Edwards Lifesciences),
and bovine pericardial annuloplasty (n  67 [11%]; Peri-Guard;
Bio-Vascular, Saint Paul, Minn). Early in the series, Carpentier
rings were used most commonly, and downsizing was inconsistent.
Since 1997, most patients have received Cosgrove bands, with a
practice of implanting 26-mm bands in women and 28-mm bands in
men (see Electronic Appendixes 1 and 2 available at www.mosby.
com/jtcvs). Median annuloplasty size was 28 mm for Cosgrove bands
and 30 mm for Carpentier rings.
Patient and procedural characteristics are presented in Table 1.
Patients receiving Cosgrove bands were more likely to have non-
cardiac comorbidity and more favorable New York Heart Associ-
ation functional class but more wall motion abnormalities.
Preoperative echocardiograms were available for analyzing
regurgitant jet direction in 477 (82%) patients (Table 2).1
Central jet direction was more common when Peri-Guard an-
nuloplasty was used. Regional wall motion abnormalities were
documented with echocardiograms or ventriculograms from
cardiac catheterization.1
Definitions
MR was considered ischemic when valve leaflets and chordae
were normal and MR was caused by consequences of a myocardial
infarction1; all patients in this study had at least one previous
myocardial infarction documented by clinical history or a segmen-
tal wall motion abnormality. Among patients with IMR, those with
The Journal of Thoracinormal papillary muscles, chordae, and leaflets were classified as
having functional IMR. Their leaflets failed to coapt, and echocar-
diograms frequently demonstrated restricted leaflet motion (Car-
pentier type IIIb leaflet motion).9
Progression of MR After Annuloplasty
Six hundred seventy-eight postrepair echocardiograms were avail-
able in 422 (75%) patients to assess the return of MR. These were
obtained sporadically, with no set schedule for echocardiographic
follow-up. Median time to postrepair echocardiography was 8
days; 75% (508) of echocardiograms were obtained within the first
2 months after the operation, and 17% (116) were obtained beyond
1 year. Patients who had a postoperative echocardiogram differed
from those who did not; the latter were more likely to be in a
higher preoperative New York Heart Association functional class,
to have required preoperative intra-aortic balloon pump support, to
have had a previous cardiac operation, and to have had more
severe preoperative MR (see Electronic Appendixes 3 and 4 avail-
able at www.mosby.com/jtcvs).
Reoperation and Survival
Patients were followed up systematically every 2 years with a
mailed questionnaire, telephone interview, or examination. Median
follow-up for reoperation and survival was 2.3 years, with 1835
patient-years of follow-up information available for analysis.
Among survivors, 25% were followed up for more than 5 years
and 10% for more than 7 years.
Data Analysis
Databases used in this study were approved by the institutional
review board for use in research.
Selection bias. Because annuloplasty type was not selected
randomly, factors associated with increased or decreased proba-
bility of a patient receiving a Carpentier ring rather than a Cos-
grove band or a Peri-Guard repair rather than a Cosgrove band
were identified (see Appendix 1 for variables used in analyses).10
From these 2 analyses, we calculated the probabilities of receiving
(1) a Cosgrove band, (2) a Carpentier ring, and (3) a Peri-Guard
repair (see Electronic Appendix 5 available at www.mosby.com/
jtcvs) for each patient. These probabilities were used as balanc-
ing scores to reduce selection bias in all analyses of
outcome.11,12
Progression of MR after annuloplasty. To estimate the prev-
alence of each MR grade across follow-up time, longitudinal
ordinal regression for repeated measurements was used (see
Electronic Appendix 5). Results are accompanied by crude
estimates of prevalence of each grade within sequential time
frames.
Factors influencing the return of MR. Factors influencing the
temporal pattern of MR after annuloplasty were identified sepa-
rately for the rapidly changing early period (first 6 months after
repair) and the stable phase thereafter. In each case, type of
annuloplasty and its balancing score were included in the analyses,
regardless of statistical significance. Other factors were sought by
using the candidate variables in Appendix 1.
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CDMitral valve replacement. Nonparametric and parametric13
methods were used to estimate freedom from mitral valve replace-
ment after annuloplasty. The number of events was too small to
TABLE 1. Patient characteristics overall and by annulopla
Characteristics n*
Entire group
(n  585)
No. (%)
Demographic
Age (y) 585
50 30 (5)
50-60 100 (17)
60-70 220 (38)
70 235 (40)
Male sex 585 350 (60)
Cardiac comorbidity
NYHA functional class 581
I 3 (0.5)
II 216 (37)
III 236 (41)
IV 126 (22)
Emergency operation 584 14 (2)
Preoperative IABP 585 88 (15)
Coronary system disease (50%) 585
0 8 (2)
1 45 (8)
2 116 (20)
3 416 (71)
MI within 14 days of
operation (acute)
585 96 (16)
Left ventricular dysfunction 584
None 48 (8)
Mild 94 (16)
Moderate 210 (36)
Severe 232 (40)
Wall motion abnormality
Anterior 544 305 (56)
Septal 544 330 (61)
Posterior 542 401 (74)
Lateral 542 310 (57)
Inferior 544 468 (86)
Atrial fibrillation 585 55 (9)
Previous CABG 585 182 (31)
Noncardiac comorbidity
Hypertension 563 407 (72)
COPD 557 154 (27)
Diabetes 566 197 (35)
Renal disease 585 59 (10)
Procedure
Tricuspid valve repair 585 62 (11)
CABG 585 554 (95)
NYHA, New York Heart Association; IABP, intra-aortic balloon pump; MI,
obstructive pulmonary disease.
*Data available.compare annuloplasty type.
918 The Journal of Thoracic and Cardiovascular Surgery ● DeceSurvival. Nonparametric and parametric multiphase hazard-
based methods13 were used to estimate survival. Risk factors
associated with the 2 hazard phases resolved were identified by
ype
Cosgrove
(n  396
[68%])
Carpentier
(n  122
[21%])
Peri-Guard
(n  67
[11%])
P valueNo. (%) No. (%) No. (%)
.2
17 (4) 9 (7) 4 (6)
72 (18) 21 (17) 7 (10)
152 (38) 36 (30) 32 (48)
155 (39) 56 (64) 24 (36)
244 (62) 64 (52) 42 (63) .2
.0008
2 (0.5) 1 (0.84) 0 (0)
159 (40) 35 (29) 22 (33)
170 (43) 44 (37) 22 (33)
64 (16) 39 (33) 23 (34)
9 (2) 1 (0.8) 4 (6) .08
50 (13) 24 (20) 14 (21) .06
.3
8 (2) 0 (0) 0 (0)
30 (8) 9 (7) 6 (9)
75 (19) 23 (19) 18 (27)
283 (71) 90 (74) 43 (64)
70 (18) 14 (12) 12 (18) .2
.4
36 (9) 9 (7) 3 (4)
69 (17) 18 (15) 7 (10)
136 (35) 43 (35) 31 (46)
154 (39) 52 (43) 26 (39)
223 (59) 55 (51) 27 (47) .1
253 (67) 53 (49) 24 (41) .0001
290 (77) 75 (69) 36 (62) .02
237 (63) 50 (46) 23 (40) .0001
332 (88) 94 (87) 42 (72) .006
37 (9) 6 (5) 12 (18) .01
119 (30) 40 (33) 23 (34) .7
287 (76) 78 (67) 42 (65) .06
124 (32) 19 (20) 11 (17) .009
150 (39) 26 (22) 21 (34) .005
42 (11) 13 (11) 4 (6) .5
47 (12) 9 (7) 6 (9) .3
370 (93) 118 (97) 66 (98) .1
ardial infarction; CABG, coronary artery bypass grafting; COPD, chronicsty t
myocusing multivariable analyses with bagging,14 according to the
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CDmethodology described in Electronic Appendix 5.15 Variables
indicating annuloplasty type and their balancing scores were in-
cluded in each hazard phase.
Presentation. Mortality and survival estimates are accompa-
nied by asymmetric 68% confidence intervals, which are compa-
rable to 1 SE.
Results
Progression of MR After Annuloplasty
Although high-grade (3 or 4) MR was uncommon im-
mediately postoperatively, the degree of MR changed rap-
idly during the first 6 months and then became relatively
stable (Figure 1, A). Overall, 28% of patients had 3 or 4
MR 6 months after the operation (Figure 1, B). Six months
after Peri-Guard annuloplasty, 66% of patients had 3 or
4 MR (Figure 2). In contrast, early and late grades of MR
were similar in patients receiving Cosgrove bands and Car-
pentier rings; with each, approximately 25% of patients had
3 or 4 MR in the first 6 months after the operation
(Figure 2).
Risk Factors for the Return of MR
Peri-Guard annuloplasty, higher grade of preoperative MR,
and jet direction other than posterior (essentially central or
complex) were associated with early return of MR (Table
3). Peri-Guard annuloplasty and more severe preoperative
left ventricular dysfunction were risk factors for late return.
Larger annuloplasty band or ring size was not identified as
a risk factor for recurrent MR.
Mitral Valve Replacement
Eleven patients had mitral valve replacement during follow-
up, with a 5-year freedom from reoperation of 97%.
Survival
There were 37 hospital deaths (6.3%); survival was 82% at
1 year and 60% at 5 years. After accounting for other
TABLE 2. Preoperative mitral valve pathophysiology by ec
Pathology
Entire group,
no. (%)
Cosgrove
no. (%)
MR jet direction (n) 477 340
Central 313 (66) 218 (64)
Anterior 12 (2.5) 8 (2.4
Posterior 110 (23) 89 (26)
Complex 42 (9) 25 (7)
MR grade (n) 585 396
2 90 (15) 74 (19)
3 288 (49) 185 (47)
4 207 (35) 137 (35)
MR, Mitral regurgitation.
*Data available.factors, neither annuloplasty type nor size was associated
The Journal of Thoraciwith time-related survival (see Electronic Appendix 6 avail-
able at www.mosby.com/jtcvs).
Discussion
Several recent studies address the effect of surgical strategy
(repair versus replacement and annuloplasty type in repair
patients) on outcome in patients with IMR.1-3,5-8 Although it
is accepted that valve repair is superior to replacement in
most patients,1-3 considerable controversy remains concern-
ing the choice of annuloplasty technique in those who
undergo repair.3,4,9 Key findings of this study are that (1)
during the first 6 months after annuloplasty for functional
IMR, important MR returns in many patients; (2) it does so
considerably more often after pericardial annuloplasty than
after Cosgrove band and Carpentier ring annuloplasty; (3)
subsequent mitral valve replacement is uncommon; and (4)
annuloplasty type does not appear to affect survival.
Progression of MR After Annuloplasty
Functional IMR results from alterations in ventricular and
annular geometry that decrease leaflet coaptation. Annulo-
plasty increases leaflet coaptation by decreasing the septal-
lateral (anterior-posterior) dimension of the mitral annulus,2
which does not address all mechanisms of functional
IMR.16
Annuloplasty alone does not ensure successful and du-
rable elimination of MR.5-9,16-18 Previous reports document
that 17% to 29% of patients experience early or late return
of 2 or greater MR.5-9,16-18 However, these studies are
small, and follow-up is limited, precluding detailed charac-
terization of the temporal pattern of MR return. Further-
more, comparison between studies might be problematic
because of different grading systems (eg, Is moderate MR
defined as 2 or 3?).
Analysis of 678 postoperative echocardiograms obtained
from a few days to 8 years postoperatively enabled us to
rdiography and Doppler interrogation
Carpentier,
no. (%)
Peri-Guard,
no. (%) P value
87 50
54 (62) 41 (82) .03
3 (3.4) 1 (2.0) .8
18 (21) 3 (6) .006
12 (14) 5 (10) .2
122 67 .03
11 (9) 5 (7)
65 (53) 38 (57)
46 (38) 24 (36)hoca
,
)examine the course of MR after annuloplasty. Most echo-
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when estimates of MR degree are most reliable. MR is
dynamic in the first 6 months after the operation and stabi-
lizes thereafter.
Risk Factors for Return of MR
Some studies have demonstrated that various forms of su-
ture annuloplasty are less durable than a prosthetic band or
ring,5,7,8 but von Oppell and colleagues17 report no differ-
ence. Posterior suture annuloplasty with pericardial but-
tressing used in this study failed to provide durable repair.
The pattern of MR return was similar to that for Cosgrove
bands and Carpentier rings. Few other reports compare
different prosthetic annuloplasty techniques. In a smaller
study with follow-up extending to only 6 weeks postoper-
atively, Aklog and associates9 found that complete resolu-
Figure 1. Progression of MR after surgical annuloplasty overall.
A, All grades of MR. Curves for each regurgitation grade repre-
sent average temporal prevalence, and they sum to 100% at each
point in time. Numbers below the horizontal axis represent echo-
cardiograms available at various time points, with the number of
patients in parentheses. B, Prevalence of regurgitation grades 3
or 4. Symbols represent crude estimates of grouped raw data.
Dashed lines are 68% confidence limits of average prevalence.tion of IMR was more likely with Carpentier rings than with
920 The Journal of Thoracic and Cardiovascular Surgery ● DeceCosgrove bands, although, as in our study, the prevalence of
residual 2 MR or greater was similar.
Recent experimental and human data confirm that the
anterior mitral annular dimension and intertrigonal distance
dilate in IMR.19-21 Some have suggested that this supports
use of a complete remodeling annuloplasty in patients with
IMR.20,21 However, it is reduction of the septal-lateral di-
mension that is most important.2 Prosthetic ring or band
annuloplasty more effectively reduces this diameter than
does suture annuloplasty,7 perhaps explaining the difference
in efficacy between these 2 techniques. However, data ex-
amining the effect of different prosthetic annuloplasty tech-
niques on septal-lateral diameter are lacking.
In addition to debate over annuloplasty type, there is
considerable discussion about annuloplasty size in patients
with functional IMR. Most surgeons advocate an undersized
annuloplasty to achieve the greatest reduction in septal-
lateral dimension.4,22,23 In patients with ischemic and non-
ischemic cardiomyopathies, Bolling and coworkers22,23
have achieved excellent early and midterm results with an
undersized flexible annuloplasty ring. However, there are
few available data to answer the following question: How
small should the annuloplasty be? Like Tahta,6 Aklog,9 and
their colleagues, we found poor correlation between annu-
loplasty size and the return of MR. However, most of our
patients received small annuloplasties (label size of 26, 28,
or 30 mm); it is possible that had more patients received
larger-sized annuloplasties, a difference in durability might
have been detected. In addition, no patient received a
24-mm annuloplasty, and those in whom a Carpentier ring
Figure 2. The effect of annuloplasty type on return of 3 or 4
mitral regurgitation. The number of echocardiograms available at
various time points is indicated, with the number of patients in
parentheses. Symbols represent crude estimates of grouped raw
data. Carpentier, Carpentier-Edwards Classic annuloplasty ring;
Cosgrove, Cosgrove-Edwards annuloplasty system; Peri-Guard,
bovine pericardial annuloplasty.was inserted received the largest sizes. Therefore, the effect
mber 2004
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could not be examined.
Several clinical factors were associated with the return of
MR. These included a higher grade of preoperative MR and
more severe left ventricular dysfunction. Von Oppell and
colleagues17 found that these factors increased the risk of
MR recurrence after suture or ring annuloplasty, and Aklog
and associates9 identified a higher grade of preoperative MR
as a risk factor for greater postoperative MR. Others have
failed to confirm these relationships.6 Jet direction also
influenced repair durability; a central jet might indicate
restriction of both the anterior and posterior leaflets, causing
more severe leaflet tenting and making restoration of coap-
tation less probable.24
Mitral Valve Replacement
Although return of MR was common, mitral valve replace-
ment was not. There are several possible explanations for
this observation. First, because nearly half of the patients
TABLE 3. Risk factors related to higher postoperative MR
Risk factor
Early MR grade change (0-6 mo)
Higher preoperative MR grade*
Smaller body size†
No ITA graft used
Jet direction other than posterior
No preoperative tricuspid regurgitation
Earlier date of operation
Interaction
Peri-Guard and earlier date of operation‡
Annuloplasty type
Cosgrove vs Carpentier
Peri-Guard vs Carpentier
Balancing scores
P_Cosgrove§
P_Peri-Guard
Late MR grade change (6 mo)
Female sex
Higher LV dysfunction grade#
Higher preoperative MR grade*
Annuloplasty type
Cosgrove vs Carpentier
Peri-Guard vs Carpentier
Balancing scores
P_Cosgrove§
P_Peri-Guard
MR, Mitral regurgitation; ITA, internal thoracic artery; LV, left ventricular.
*(Preoperative mitral regurgitation)2 squared transformation.
†Ln(body surface area) logarithmic transformation.
‡Peri-Guard annuloplasty with date of operation (interaction term).
§Probability of patient receiving Cosgrove band.
Probability of patient receiving Peri-Guard annuloplasty.
#Left ventricular dysfunction (grades 3 or 4 vs 1 or 2; yes/no).died within 5 years of the operation, the competing risk of
The Journal of Thoracideath might have limited the number of patients available
for reoperation. Second, IMR after annuloplasty might be
considered inconsequential compared with the underlying
myocardial disease. Third, surgeons might be hesitant to
perform a second or third cardiac operation in these elderly,
high-risk patients.
Survival
As in other studies of patients with IMR, survival was
limited.1-3 Although our previous study demonstrated that
pericardial annuloplasty reduced survival in patients with
IMR undergoing mitral valve repair, the analysis included
patients with all forms of IMR, including papillary muscle
pathology. In contrast, this study focuses on that subset of
patients with functional IMR, and in this population we
found little association between annuloplasty type and sur-
vival. These results do not preclude a survival effect of other
annuloplasty techniques not used in this study. In fact,
comparing suture annuloplasty with a remodeling ring,
e
Coefficient  SE P value
0.12 0.025 .0001
2.8  0.81 .0007
0.68 0.22 .002
0.54 0.28 .05
0.57 0.26 .03
0.101 0.039 .009
0.59 0.17 .0006
0.31 0.33 .4
5.2 1.4 .0002
0.53 0.71 .4
0.29 0.99 .8
0.99 0.502 .05
1.2 0.57 .03
0.095 0.052 .06
0.64 0.57 .3
1.9 0.72 .008
0.085 1.8 .9
1.9  1.5 .2gradGrossi and coworkers5 demonstrated reduced survival with
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identify annuloplasty type as a risk factor.9,17
Limitations
Most of this study’s findings are based on analysis of
postoperative echocardiograms. Systematic scheduling of
echocardiographic follow-up is not possible outside a clin-
ical trial.1,6,9 Although most patients had a predischarge
echocardiogram, late echocardiograms were obtained spo-
radically at the cardiologists’ discretion. Comparing pa-
tients who received postoperative echocardiograms with
those who did not revealed some differences (see Electronic
Appendixes 3 and 4). Patients without postoperative echo-
cardiograms had a higher degree of preoperative MR, a
factor related to more severe postoperative MR. This sug-
gests that high-grade postoperative MR might be underes-
timated. Most echocardiograms were obtained in the first
year after the operation, the time of greatest change in MR
grade. However, 17% of echocardiograms were obtained
beyond that point, providing sufficient data to characterize
the temporal pattern of MR.
Because this was not a randomized study, there were
differences among patients receiving different annuloplasty
types. Multivariable analyses and balancing scores were
used to account for these differences.
It is possible that detailed analysis of preoperative echocar-
diographic dimensions will reveal quantifiable risk factors for
annuloplasty failure. In fact, Calafiore and associates24 has
suggested that excessive leaflet tenting jeopardizes repair.
We cannot address in a formal fashion the relationship
between progression of MR and survival. Others have sug-
gested that MR recurrence jeopardizes survival,9,17 but to
our knowledge, statistical methodology to test this hypoth-
esis properly does not exist. Both recurrent MR and death
are outcomes of surgical intervention. Examination of their
interdependence and their relationship to surgical technique
requires the development of novel statistical methodology.
Clinical Inferences
A prosthetic annuloplasty band or ring should be used in
patients with functional IMR. During the first 6 months
thereafter, patients should be followed closely by using
echocardiography. Although initial mitral valve replace-
ment would eliminate the risk of postoperative MR, this
strategy is associated with reduced survival in most patients
with IMR.1 Therefore, development of additional tech-
niques is necessary to achieve more secure repair of func-
tional IMR.
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Discussion
Dr D. Craig Miller (Stanford, Calif). Thank you, Dr McGee, for
a very fine presentation. You should be proud. Number one, I
would like to compliment The Cleveland Clinic Foundation for
your honesty. This is an important contribution.
mber 2004
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CDUnlike mitral valve prolapse, in which the standard of care is to
leave zero or negligible residual MR after repair, surgeons have
played ostrich for far too long in overlooking the repair failures
that we leave behind in patients with IMR. Why have we over-
looked these shortcomings? For one, in many cases we most likely
were just glad to have a survivor.
The debate about whether you should intervene in those cases
with moderate IMR when you are performing coronary revascu-
larization remains open, but most of the world now thinks you
should do something to the valve if the degree of MR is more than
2 on a preoperative transthoracic echocardiogram.
I have one minor quibble—despite being a believer in Gene
Blackstone’s statistical magic—which concerns the echocardio-
graphic data. The median time for all echocardiographic studies
was only 8 days postoperatively; you had an echocardiogram
within 2 months in 75% of patients but beyond 1 year in only 17%.
Yet your curves showing the recurrent rates of MR were drawn
way out to 4 and 5 years, and I did not see any confidence levels
or variability of the estimates, which I would expect from Dr
Blackstone. Are you not extrapolating beyond what the data set
reliably allows?
Dr McGee. Thank you very much for your comments, Dr
Miller. We are all very much indebted to you for furthering our
understanding of the complex functional anatomy of the mitral
valve.
To answer your question, it is true that most of our echocardio-
grams were early, and 17%, as you mentioned, were after 1 year, but
we did have points out to that far, and we believe our data. In addition,
the echocardiograms that were obtained sporadically were done so in
symptomatic patients, and it also seemed to be in patients who had
more complex jets. Therefore it is likely that we were somewhat
pessimistic in the return of MR, and if there is any error, it is going to
be an overestimate of recurrent MR.
Dr Miller. Were these postoperative studies all Cleveland
Clinic echocardiograms?
Dr McGee. Yes, they were all Cleveland Clinic echocardio-
grams, and they were all transthoracic studies.
Dr Miller. That explains why you do not have too many late
studies, even though many were probably done elsewhere. I could
turn your argument against you and speculate that this is actually
an overly rosy estimate of the recurrent rate of IMR because you
do not have complete echocardiographic follow-up information.
Perhaps those with more severe recurrent MR and poorer left
ventricular (LV) function had succumbed and therefore did not
return to get a Cleveland Clinic Foundation postoperative echo-
cardiogram. But that is an imponderable result, so let’s drop it for
now.
On your echocardiographic studies, were there any substantial
mitral gradients? This is pertinent because in Dr Rankin’s and Dr
Glower’s article, they were using 24- to 26-mm rings. What was
the average mitral mean gradient? Are we creating any important
degree of functional mitral stenosis by using these teeny rings?
Dr McGee. To my knowledge, there were not any gradients
created by overdownsizing.
Dr Miller. Finally, in 2002-2003, use of the Cosgrove band
dipped, whereas use of the Carpentier-Edwards Classic ring in-
creased. What is the current practice today since the completion of
this study?
The Journal of ThoraciDr McGee. That would depend on which surgeon you spoke
with.
Dr Miller. A very prudent answer; that is what I thought you
would say.
Regarding the reoperation rate, it is low, with 97% free at 5
years, and you give us 3 reasons in the article why that might be
so. Interestingly, that was the identical number Dr Glower just
presented. But is it really fair to compare reoperation rates after
repair for prolapse with reoperation for IMR? That is an apples to
oranges comparison and just does not compute. I would wager that
many patients with recurrent MR were just too sick or too old or
both to even consider reoperating on them, which is distinctly
different than younger patients after prolapse repair; this might be
the main reason why even though 25% had severe MR 6 months
later, more did not undergo reoperation. Would you agree?
Dr McGee. Yes, sir.
Dr Miller. That represents good judgment.
Dr Bruce W. Lytle (Cleveland, Ohio). I would like to interject
something here. The interesting thing about it is, though, that the
unadjusted survival rate of these patients is also identical to the
unadjusted survival rate of Dr Glower’s and Dr Rankin’s patients,
which is 55% at 5 to 6 years. Therefore whatever is going on there,
these are very similar groups of patients in terms of survival.
Dr Miller. That is a good point, Bruce.
Finally, if we can break through our denial, which is always
tough for a surgeon, and accept that simple ring annuloplasty is not
enough for patients with IMR, is there anything we can add to a
ring at the ventricular level to improve things, such as a Coapsys
device or other method of LV reshaping? Or should we swallow
our pride and do a straightforward, quick, and reliable total chord-
al-sparing mitral valve replacement with a bioprosthesis? Recall
that 4 years ago at this meeting, the Cleveland Clinic group
actually showed a 7-year survival advantage for mitral valve
replacement over repair in the sickest of the 5 quintiles.
Dr McGee. That is a very good point.
I think there are some reports of chordal lengthening, but that
currently is not done at the Cleveland Clinic. In certain patients I
think a chordal-sparing mitral valve replacement is a good treat-
ment. The majority of patients with ischemic MR, I think, will
benefit from a ring annuloplasty, but patients with bileaflet teth-
ering, severe LV dysfunction, and very complex jets, who are
extremely sick, would most likely be best served by a chordal-
sparing replacement with a bioprosthetic valve.
Dr Miller. I agree, and they certainly do not live long enough
to need a mechanical valve. Historically, the very poor results we
all remember after mitral valve replacement and coronary artery
bypass grafting from decades ago might have been due to subop-
timal myocardial protection and cutting out the whole valve and
subvalvular apparatus.
Dr David Adams (New York, NY). Just another comment about
apples and oranges. You used your Carpentier rings predominantly
early in the late 1980s. You were not downsizing; your histograms
showed your average size was 30 mm, and more were 30, 32, and
34 mm. The majority of your Cosgrove bands were size 26 and
size 28 mm. It appears you had a different strategy in terms of size
selection over the period of the study. Could you comment on that
and how you think that might affect your direct comparison of the
2 rings?
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CDDr McGee. Thank you, Dr Adams. Sizing is also a function of
surgeon preference. Most surgeons downsize at least 2 sizes, but
your point that the Cosgrove bands tended to predominate in the
smaller sizes is well taken. That was corrected per the numbers, but
we were not able to demonstrate a difference, as you pointed out.
Dr Robert Frater (Broxville, NY). Your title implies very
distinctly a comparison between different techniques: 2 of them are
very standard in being rigid rings, and the third is a technique that
requires a great deal of art to make it work at all. You obviously have
condemned the pericardial annuloplasty. Would it not be fairer to say
that “in our hands we were not able to make the pericardial annulo-
plasty work” rather than saying, given your experience, that it is
automatically for everybody else a bad technique?
Dr McGee. Thank you, Dr Frater. One of the problems with
looking at the pericardial annuloplasties was that there did not
seem to be a systematic way of sizing them, and there was a lot of
variability in that. From our understanding, most were sized to a
26-mm sizer, but that is one of the problems. It is not a standard-
ized method, and because of that, it is hard to reproduce.
Dr Alain Carpentier (Paris, France). Well, I just rise to give924 The Journal of Thoracic and Cardiovascular Surgery ● Deceischemic valvular disease there is a predominant dilatation in the
P3 area, and as pointed out by the previous speaker, you use, in this
case, pledget-supported sutures. Another alternative that I like to
use in this particular area is a double-roll suture. In other words, if
you place 2 rolls of sutures, then you prevent the potential ring
dehiscence.
Dr Thoralf Sundt III (Rochester, Minn). Did I understand one
of your final slides to show no correlation between annuloplasty
technique and survival?
Dr McGee. Yes, there was no difference in terms of survival
when it was corrected.
Dr Sundt. When it was corrected?
Dr McGee. For patient factors.
Dr Sundt. Therefore, if there is a profound difference in
residual MR according to technique and no difference in survival
according to technique, does that not imply that there is no corre-
lation between survival and correction of the MR?
Dr McGee. We did not look specifically at survival and recur-
rent MR, because after extensive discussions with Dr Blackstone,
we are not aware of a way to do that with the current statisticala small technical recommendation; that is, we all know that in methodology.mber 2004
Appendix 1
Variables used in analyses
Preoperative
Demographic Age (y), sex, weight (kg), height (cm), body surface area (m2), body mass index (kgm2)
Symptoms New York Heart Association functional class (I-IV), emergency operation, acute
myocardial infarction, remote myocardial infarction
Ventricular dysfunction Degree of left ventricular dysfunction (1  none, 2  mild, 3  moderate, 4  severe),
wall motion (anterior, posterior, septal, lateral, inferior)
Mitral valve pathophysiology Jet direction (central, anterior, posterior, complex), mitral regurgitation
Other valve pathophysiology Aortic regurgitation, tricuspid regurgitation
Cardiac comorbidity Atrial fibrillation, complete heart blocker-pacer, ventricular arrhythmia, prior cardiac
operation, emergency operation, no. of previous cardiac operations
Noncardiac comorbidity Insulin-treated diabetes, non–insulin-treated diabetes, treated diabetes, history of
peripheral vascular disease, history of smoking, carotid disease, chronic obstructive
pulmonary disease, hypertension, renal disease, creatinine (mgdL1), blood urea
nitrogen (mgdL1), bilirubin (mgdL1), hematocrit (%)
Coronary anatomy Left main trunk disease (% stenosis), left anterior descending coronary artery system
disease (maximum % stenosis), right coronary artery system disease (maximum %
stenosis), left circumflex coronary artery system disease (maximum % stenosis)
Experience Date of operation (years since January 1, 1985)
Intraoperative
Procedure Annuloplasty type, device size (Carpentier and Cosgrove annuloplasties), coronary artery
bypass grafting, internal thoracic artery graft used, tricuspid valve repair, aortic clamp
time (min), cardiopulmonary bypass time (min)
Electronic Appendix 1. Annuloplasty type use by calendar year. Proportion of patients receiving Carpentier-Edwards
classic annuloplasty ring (open circles), Cosgrove-Edwards annuloplasty system (filled circles), and Peri-Guard bovine
pericardial annuloplasty (open squares) by year of operation.
Electronic Appendix 2. Annuloplasty ring size. Number of patients receiving each annuloplasty ring size.
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Patient and procedural characteristics of patients with versus those without postoperative echocardiographic studies
Characteristic n*
With postoperative
echo (n  422),
no. (%)
Without postoperative
echo (n  163),
no. (%) P value
Demographic
Age (y) 585 .99
50 22 (5) 8 (5)
50-60 73 (17) 27 (17)
60-70 159 (38) 61 (37)
70 168 (40) 67 (41)
Male 585 250 (59) 100 (61) .6
Cardiac comorbidity
NYHA functional class 581 .01
I 3 (0.7) 0 (0)
II 165 (39) 51 (32)
III 176 (42) 60 (38)
IV 77 (18) 49 (31)
Emergency operation 584 9 (2) 5 (3) .5
Preoperative IABP 585 52 (12) 36 (22) .003
Left main disease (50%) 584 108 (26) 46 (28) .5
LAD disease (50%) 584 376 (89) 147 (90) .8
Circumflex disease (50%) 584 343 (81) 133 (82) .97
Right coronary disease (50%) 585 381 (90) 145 (89) .6
Coronary system disease (50%) 585 .8
0 6 (1.4) 2 (1.2)
1 34 (8) 11 (7)
2 80 (19) 36 (22)
3 302 (72) 114 (70)
MI within 14 days of operation (acute) 585 68 (16) 28 (17) .8
LV dysfunction 584 .2
None 40 (10) 8 (5)
Mild 71 (17) 23 (14)
Moderate 145 (34) 65 (40)
Severe 165 (39) 67 (41)
Wall motion abnormality
Anterior 544 236 (59) 69 (47) .01
Septal 544 258 (65) 72 (49) .001
Posterior 542 302 (76) 99 (68) .05
Lateral 542 244 (62) 66 (45) .0006
Inferior 544 346 (87) 122 (84) .3
Atrial fibrillation 585 41 (10) 14 (9) .7
Previous cardiac operation 585 102 (24) 80 (49) .0001
Noncardiac comorbidity
Hypertension 563 303 (74) 104 (67) .09
COPD 557 120 (29) 34 (24) .2
Diabetes: treated 566 148 (36) 49 (32) .3
Diabetes: insulin treated 557 66 (16) 27 (18) .7
Diabetes: noninsulin treated 557 99 (24) 25 (16) .04
Renal disease 585 38 (9) 21 (13) .2
Procedure
Tricuspid valve repair 585 53 (12) 9 (6) .01
CABG 585 394 (93) 160 (98) .02
ECHO, Echocardiogram; NYHA, New York Heart Association; IABP, intra-aortic balloon pump; LAD, left anterior descending coronary artery; MI, myocardial
infarction; LV, left ventricular; COPD, chronic obstructive pulmonary disease; CABG, Coronary artery bypass grafting.
*Data available.
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Electronic Appendix 5. Details of Statistical Models
Bias Reduction
We used PROC LOGISTIC (SAS Institute, Inc, Cary,
NC) with generalized logit link and the Cosgrove group as
the reference group to generate 2 simultaneous multivari-
able logistic regression equations that identified factors as-
sociated with group membership (Carpentier ring group and
Peri-Guard annuloplasty group) relative to the Cosgrove
band group by using known preoperative variables (Appen-
dix 1 and Table 1). Continuous and ordinal variables were
initially analyzed by means of decile analysis, selecting
those transformations of scale that best linearized their
relationship to group membership. Having established a
parsimonious model, we added other variables representing
groups of patients and coronary disease factors that might
be related to unrecorded selection factors (saturated mod-
el).11
Three propensity scores (propensity for receiving Cos-
grove band, Carpentier ring, and Peri-Guard annuloplasty)
were calculated for each patient by solving the 2 simulta-
neous multivariable logistic regression equations. Two of
the 3 scores and their transformations, where appropriate,
were then forced into multivariable analyses as balancing
scores to reduce selection bias.10,12
Temporal Pattern of Follow-up MR
Longitudinal ordinal regression was used to analyze the
repeated measurements of postoperative and follow-up MR
grade (PROC GENMOD, SAS Institute).
Factors Influencing MR Development
For MR grade measurements made within 6 months of
repair, and separately for those made after 6 months, we
initially screened variables by using ordinary multivariable
logistic regression (PROC LOGISTIC, SAS Institute) and
the assumption of independence of observations, with lib-
eral entry (0.2) and retention (0.12) criteria. Because of the
limited capability of PROC GENMOD to explore multiva-
riable relations, this analysis was performed simply to iden-
tify possible candidates for our repeated measurements
model. These candidate variables and their transformations,
if any, were entered simultaneously into a longitudinal
logistic regression model (PROC GENMOD) and then
eliminated one by one until all variables remaining had a P
value of .1 or less.
Survival
A parametric model was used to resolve the number of
phases of instantaneous risk of death (hazard function) and
to estimate shaping parameters.13 Multivariable analysis
was performed in the hazard function domain. Preoperative
and intraoperative variables used in the analyses are listed in
Appendix 1, and variable selection was by bootstrap bag-
ging, with a retention criterion of a P value of .05 or less.14
Cosgrove band and Peri-Guard annuloplasty indicators were
forced into each hazard phase (leaving Carpentier ring as
the reference group), as were the two balancing
scores.10,12
Electronic Appendix 4.
Preoperative mitral valve pathophysiology in patients with versus those without postoperative echocardiographic studies
Characteristic
With postoperative
echo, no. (%)
Without postoperative
echo, no. (%) P value
MR jet direction (n) 358 119
Central 232 (65) 81 (68) .5
Anterior 9 (2.5) 3 (2.5) .9
Posterior 89 (25) 21 (18) .1
Complex 28 (8) 14 (12) .2
MR grade (n) 422 163 .04
2 75 (18) 15 (9)
3 201 (48) 87 (53)
4 146 (35) 61 (37)
MR, Mitral regurgitation.
*Data available.
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Risk factors for death after repair
Risk factor Coefficient  SD P value Reliability (%)*
Early hazard phase
Older† 0.44 0.20 .03 60
Higher NYHA class‡ 0.16 0.035 .0001 78
Higher creatinine§ 2.3 0.52 .0001 92
Higher LV dysfunction grade 0.37 0.16 .02 64
Jet direction: complex 1.2 0.43 .005 49
Earlier date of operation 0.12 0.049 .02 64
Annuloplasty type
Cosgrove vs Carpentier 0.33 0.46 .3
Peri-Guard vs Carpentier 0.49 0.45 .3
Balancing scores
P_Cosgrove 2.8 0.93 .003
P_Peri-Guard# 1.2 1.2 .3
Late hazard phase
Smaller body mass index** 1.7 0.43 .0001 94
Previous cardiac operation 0.53 0.19 .02 49
Higher creatinine§ 1.6 0.35 .0001 99
Lower hematocrit†† 3.9 0.90 .0001 53
Annuloplasty type
Cosgrove vs Carpentier 0.44 0.24 .07
Peri-Guard vs Carpentier 0.069 0.25 .8
Balancing scores
P_Cosgrove 0.15 0.57 .8
P_Peri-Guard# 0.66 0.76 .4
NYHA, New York Heart Association; LV, left ventricular.
*Frequency of occurrence in bootstrap models.
†Exp(age/50) exponential transformation.
‡(New York Heart Association class)2 squared transformation.
§(1/creatinine) inverse transformation.
Probability of patient receiving a Cosgrove band.
#Probability of patient receiving Peri-Guard annuloplasty.
**(1/body mass index) inverse transformation.
††Ln(hematocrit) logarithmic transformation.
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